文献速递瓣膜外科

慢性主动脉瓣反流行主动脉瓣置换术的结局:胸外科医师学会数据库分析

Outcomes of Aortic Valve Replacement for Chronic Aortic Insufficiency: Analysis of the Society of Thoracic Surgeons Database.
PubMed 文献 · Ann Thorac Surg · 2021-04-25

该研究基于STS成人心脏外科数据库,纳入2011年7月至2018年12月间因中度及以上主动脉瓣反流接受孤立性外科主动脉瓣置换术的患者,排除合并中度及以上狭窄、急性夹层、活动性心内膜炎、同期手术或急诊手术者。共12,564例患者,按指南标准进行AI分期,比较各期手术死亡率和并发症,并识别手术死亡危险因素。结果显示总体手术死亡率为1.1%,随分期进展(C1、C2、D期)死亡率和主要并发症均显著增加,严重心室扩张且射血分数低于0.30者死亡率更高。结论认为孤立性SAVR治疗AI的手术风险在全国队列中很低,为未来经导管方法提供了基准,手术风险随心室重构进展而增加,在严重AI患者出现心室重构前行SAVR可能是合适的。

要点

  • 孤立性SAVR治疗AI的总体手术死亡率为1.1%,主要并发症发生率随AI分期进展而增加。
  • AI分期D期患者占57.5%,其手术死亡率(1.6%)显著高于C1期(0.4%)和C2期(0.7%)。
  • 严重心室扩张且射血分数低于0.30者手术死亡率(2.7%)显著高于无此情况者(1.0%)。

核心结论

  • 在全国队列中,孤立性SAVR治疗AI的手术死亡率和并发症发生率很低,为未来经导管方法提供了基准。
  • 手术风险随晚期心室重构而增加,在严重AI患者出现心室重构前行SAVR可能是合适的。

研究设计与样本

  • 回顾性分析STS成人心脏外科数据库,纳入2011年7月至2018年12月间因中度及以上AI行孤立性SAVR的患者,排除合并中度及以上狭窄、急性夹层、活动性心内膜炎、同期手术或急诊手术者,共12,564例。
  • 按指南标准基于症状和心室重构对AI进行分期,比较各期手术死亡率和并发症,并识别手术死亡危险因素。

主要发现

  • 患者最常见的AI分期为D期(7019例,57.5%),其次为B期(1405例,11.2%)、C1期(1128例,9.0%)、C2期(1325例,10.5%)。
  • 总体手术死亡率为1.1%,C1、C2、D期分别为0.4%、0.7%、1.6%(P < .01),主要并发症分别为5.1%、7.5%、9.9%(P < .01)。
  • 严重心室扩张且射血分数低于0.30者手术死亡率为2.7%,显著高于无此情况者的1.0%(P < .01)。
  • 手术死亡的危险因素包括有症状的AI、射血分数降低、年龄、体重、体表面积和透析。

临床怎么用

  • 对于严重AI患者,应考虑在心室重构发生前进行SAVR,以降低手术风险。
  • AI分期(尤其是C1、C2、D期)和心室重构程度可用于术前风险分层和手术时机决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study evaluated outcomes and risk factors for surgical aortic valve replacement (SAVR) for aortic insufficiency (AI) in a national cohort. We analyzed the incidence, outcomes, and risk factors for SAVR for AI in the Society of Thoracic Surgeons Adult Cardiac Surgery Database. METHODS: The national database was queried for patients with moderate or greater AI undergoing isolated SAVR between July 2011 and December 2018. Patients with moderate or greater aortic stenosis, acute dissection, active endocarditis, concomitant procedures, or emergent operation were excluded. AI was staged using guideline criteria based on symptoms and ventricular remodeling. Operative mortality and morbidity were compared between stages, and risk factors for operative death were identified. RESULTS: A total of 12,564 patients underwent isolated SAVR for AI from 2011 to 2018. Patients were most frequently AI stage D (7019 [57.5%]), compared with B (1405 [11.2%]), C1 (1128 [9.0%]), or C2 (1325 [10.5%]). Operative mortality was 1.1% overall, and increased between stage C1, C2, and D (0.4% vs 0.7% vs 1.6%, respectively, P < .01), along with major morbidity (5.1% vs 7.5% vs 9.9%, respectively; P < .01). Mortality was higher in patients with severe ventricular dilation and an ejection fraction of less than 0.30 (2.7% vs 1.0%, P < .01). Risk factors for death were symptomatic AI, decreased ejection fraction, age, weight, body surface area, and dialysis. CONCLUSIONS: Operative mortality and morbidity for isolated SAVR for AI is very low in a national cohort, providing a benchmark for future transcatheter approaches. Operative risk increases with advanced ventricular remodeling. SAVR before development of ventricular remodeling may be appropriate in patients with severe AI.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ryan CT, Almousa A, Zea-Vera R, et al. Outcomes of Aortic Valve Replacement for Chronic Aortic Insufficiency: Analysis of the Society of Thoracic Surgeons Database. Ann Thorac Surg. 2021. PMID: 33910050. doi:10.1016/j.athoracsur.2021.04.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。